Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnost… Read more
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.032x
Based on the latest financial reports, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a cash flow conversion efficiency ratio of 0.032x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.11 Million) by net assets (CN¥2.73 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gray Television Inc
NYSE:GTN-A
|
0.040x |
|
China Suntien Green Energy Corporation Limited
PINK:CSGEF
|
0.094x |
|
Chengdu Haoneng Tech Co Ltd
SHG:603809
|
0.000x |
|
Gelex Group JSC
VN:GEX
|
0.143x |
|
Hunan Friendship&Apollo Commercial Co Ltd
SHE:002277
|
0.015x |
|
TOWA Corporation
F:TWA
|
N/A |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
0.084x |
|
Nippon Light Metal Holdings Company Ltd
F:N9L
|
N/A |
Annual Cash Flow Conversion Efficiency for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.46 Billion | CN¥262.44 Million | 0.107x | -36.68% |
| 2023-12-31 | CN¥2.30 Billion | CN¥388.32 Million | 0.169x | -5.16% |
| 2022-12-31 | CN¥2.03 Billion | CN¥360.28 Million | 0.178x | -11.44% |
| 2021-12-31 | CN¥1.80 Billion | CN¥360.58 Million | 0.201x | +19.70% |
| 2020-12-31 | CN¥1.53 Billion | CN¥256.22 Million | 0.168x | -2.68% |
| 2019-12-31 | CN¥1.35 Billion | CN¥232.93 Million | 0.172x | -16.93% |
| 2018-12-31 | CN¥995.42 Million | CN¥206.45 Million | 0.207x | +4.43% |
| 2017-12-31 | CN¥801.26 Million | CN¥159.13 Million | 0.199x | +6.05% |
| 2016-12-31 | CN¥655.58 Million | CN¥122.77 Million | 0.187x | -4.93% |
| 2015-12-31 | CN¥582.91 Million | CN¥114.82 Million | 0.197x | +20.85% |
| 2014-12-31 | CN¥513.55 Million | CN¥83.70 Million | 0.163x | -29.58% |
| 2013-12-31 | CN¥251.92 Million | CN¥58.30 Million | 0.231x | +1.97% |
| 2012-12-31 | CN¥181.38 Million | CN¥41.17 Million | 0.227x | +51.24% |
| 2011-12-31 | CN¥127.61 Million | CN¥19.15 Million | 0.150x | -6.64% |
| 2010-12-31 | CN¥90.44 Million | CN¥14.54 Million | 0.161x | +42.42% |
| 2009-12-31 | CN¥111.89 Million | CN¥12.63 Million | 0.113x | -- |